Akero Therapeutics Inc (NASDAQ:AKRO)
| 38.10 Delayed Data As of 3:59pm ET |  -2.13 / -5.29%Today’s Change | 7.52 Today|||52-Week Range 54.88 | -30.47% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Skorpios Trust |  Sale | 12/01/2022 | 1,636,000 | $43.50 | $71.2M | -16.59% |
White William R /akero/ Chief Financial Officer | Sale | 12/27/2022 | 19,001 | $49.77 | $945.7K | -23.35% |
Harrison Seth L Director | Sale | 10/28/2022 | 22,096 | $40.28 | $890.0K | -6.62% |
Rolph Timothy Chief Scientific Officer | Sale | 10/06/2022 | 22,500 | $39.29 | $884.0K | -2.93% |
Harrison Seth L Director | Sale | 10/28/2022 | 20,338 | $40.28 | $819.2K | -6.62% |
White William R /akero/ Chief Financial Officer | Sale | 10/13/2022 | 20,000 | $39.82 | $796.4K | -5.15% |
Rolph Timothy Chief Scientific Officer | Sale | 9/30/2022 | 22,500 | $34.06 | $766.4K | +11.92% |
Cheng Andrew President & Chief Executive Officer | Sale | 3/01/2023 | 16,035 | $46.60 | $747.2K | -19.09% |
Cheng Andrew President & Chief Executive Officer | Sale | 2/01/2023 | 14,845 | $48.57 | $721.0K | -22.59% |
Rolph Timothy Chief Scientific Officer | Sale | 9/30/2022 | 22,500 | $31.38 | $706.1K | +11.92% |
Page of 9